4 vials — 10% off · 10 vials — 20% off | Volume discounts applied automatically at checkout
peptides-pro — research peptides

5-Amino-1MQ fat loss claims: what mitochondrial research actually shows

A TikTok claims 5-Amino-1MQ boosts metabolism and fat loss by making mitochondria work smarter. We review the evidence behind this cellular-level peptide.

5-Amino-1MQ fat loss claims: what mitochondrial research actually shows

A viral TikTok clip from @genxnp76 presents 5-Amino-1MQ as a peptide that “works at the cellular level to support fat loss, boost metabolism, and increase energy.” The caption urges viewers to “think beyond calories” and suggests the compound helps mitochondria “work smarter, not harder.” While the framing is catchy, the underlying science is more nuanced than the video implies.

What the clip claims

The video’s core assertion is that 5-Amino-1MQ directly enhances mitochondrial function, leading to increased fat oxidation and metabolic rate. It implies that this peptide can override caloric balance—a claim that oversimplifies energy homeostasis. The hashtag #longevity further positions it as an anti-aging intervention.

What the research neighborhood actually covers

5-Amino-1MQ is a small molecule that has been studied primarily in preclinical models. It is known to inhibit the enzyme NNMT (nicotinamide N-methyltransferase), which plays a role in cellular metabolism. In rodent studies, NNMT inhibition has been associated with increased energy expenditure and reduced fat mass. However, these findings are preliminary and have not been replicated in human clinical trials. The peptide’s bioavailability, dosing, and long-term safety remain unknown. Moreover, the term “peptide” is technically inaccurate—5-Amino-1MQ is a substituted quinazoline, not a peptide. This distinction matters for research-use clarity.

Limits of the evidence

No peer-reviewed human studies have demonstrated that 5-Amino-1MQ causes fat loss or boosts metabolism in people. The TikTok’s language—“supports,” “boosts,” “helps”—is suggestive but not evidence-based. Mitochondrial “smarter” work is a metaphor, not a measurable endpoint. Caloric balance remains the primary determinant of weight change; any peptide’s effect would be adjunctive at best. Furthermore, the compound is not approved for human use by regulatory agencies, and its research-use-only status means it is not intended for clinical application.

Research-use caveat

For researchers, 5-Amino-1MQ is an intriguing tool for studying NNMT pathways and mitochondrial metabolism in vitro or in animal models. But extrapolating these findings to human weight loss or energy claims is premature. As with all research chemicals, handling should follow institutional guidelines, and any human use is strictly prohibited outside approved clinical trials.

Open the full video fact-check page (transcript, takeaways, embedded clip).

WhatsApp